Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if DSC127 is effective in increasing incidence of
complete wound closure at 10 weeks confirmed at a visit 2 weeks later when compared to the
vehicle (gel without active ingredient) in subjects with diabetes mellitus (DM) who have
chronic Wagner Grade 1 or 2 plantar neuropathic foot ulcers, 0.75 - 6 cm2 in size.
Phase:
Phase 3
Details
Lead Sponsor:
Derma Sciences, Inc. Integra LifeSciences Corporation